Pneumothorax in cystic fibrosis.

  • Kioumis I
  • Zarogoulidis K
  • Huang H
 et al. 
  • 17


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Pneumothorax is recognized as a common and life-threatening complication in cystic fibrosis (CF) patients, especially in those who are infected with P. aeruginosa, B. cepacia or Aspergillus, need enteral feeding, are diagnosed as suffering from allergic bronchopulmonary aspergillosis (ABPA), developed massive hemoptysis, and their respiratory function is seriously compromised. Structural impairment and altered airflow dynamics in the lungs of CF patients are considered as the main predisposing factors, but also inhaled medications and non-invasive positive pressure ventilation (NIPPV) could increase the risk of pneumothorax. Clinical presentation could range from dramatic to very mild. Management of spontaneous pneumothorax occurring to patients with CF is essentially similar to that for non-CF patients. Therapeutic options include intercostal tube drainage, video-assisted thoracoscopic surgery (VATS), and medical or surgical pleurodesis. Pneumothorax increases both short- and long-term morbidity and mortality in CF patients and causes significant deterioration of their quality of life.

Author-supplied keywords

  • 01
  • 09
  • 10
  • 2014
  • 2072-1439
  • 27
  • 3978
  • accepted for publication sep
  • antibiotics
  • cf
  • cystic fibrosis
  • doi
  • dx
  • http
  • issn
  • j
  • macrolides
  • org
  • pneumothorax
  • submitted aug 31
  • view this article at

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Ioannis P Kioumis

  • Konstantinos Zarogoulidis

  • Haidong Huang

  • Qiang Li

  • Georgios Dryllis

  • Georgia Pitsiou

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free